《华南地区年轻乳腺癌患者的临床特征及》由会员分享，可在线阅读，更多相关《华南地区年轻乳腺癌患者的临床特征及（7页珍藏版）》请在金锄头文库上搜索。
1、!“华南肿瘤学国家重点实验室!广东 广州#!$%$;“ 653/%?“ ;“ 653/%通讯作者! 王思愚()*+,-)./+.0+ 1)“23456 78.9:+;?ABC83;“D,E,6C,FG3-修回日期! )J (8.0+*#5/+%:*3/-.%41$5+.#A %/4 9 BC8 :$+.:(%2“. 3-.*.$3/(+/4 3/%2.$%+ 5.-. .“/4(/%.D$52%61#,7$#PQQ *$%PKS “+O RBOTS$!6COCCT+%.#“.- ($) 3/%2.$%$,-./+% 0/$0.-$042$20/4 0$MN2;?阳性率之间的差异均无统计学意义(
2、!0(0?BCBHFB=IBJK ,EBLFKMNOC ,9PFB“Q ,EBEM,6O,9E9+F “QBRS% ,EBLFIEFNKOEBT 6O,9E9+F CBEF UV0* KOEBT 6O,9E9+F CBEF UV0* KOEBT WWXWWW KOEBT 6O,9E9+F CBEF !G1* KOEBT 61) NMEBE9OY KOEBT 6O,9E9+F CBEF V0* KOEBT V G ) KOEBT =I JCF,FYEFH KOEBT JK0 JKV JKG JK) JK- KOEBT “G DN G DN KOEBT JQ0 Z ,FYE9YFT YOHF YF
3、LBE9+F JQV JQG JQ) KOEBT 0 VX) -X. !V0 KOEBT 0 ! “ #=FC OMYL JBE9FYE,)YMNFC(*$* V2 1#-1(1$ V2 3#)3(-$ V2 20#)2(-$ V2 2V#).(.$ V0 VV2#31(0$ V2. V0-#1(V$ V)V 2#1()$ 21#12()$ -.#)2(-$ V23 G)#V)(V$ V2 G#V(V$ 1)#G()$ V0V#1-(0$ V-#2(1$ V2#.(V$ V1 1-#G.(G$ V)V#20($ V. 0#-G()$ 1#)0(2$ G1#V)(G$ G3#V)($ V3 0#
4、-)(0$ 13#)0(V$ G-#VG(.$ G3#V-(0$ V. G#V(0$ G#V-($ .#1V(.$ 3V#)G()$QOYOMYL JBE9FYE,)YMNFC#*$* 200 .1#-(V$ 20V -#)1(-$ 3.3 0#)V(3$ 32V )0#-1(0$ 33) -.#2)($ 320 -3#3)(3$ )21 #1(.$ V#10(V$ V31#-(0$ -3 )#3($ 2V- 1#0(2$ )0#)($ ).0#1-(3$ 12#(0$ )#-(1$ 2V0 )#)($ -22#32($ 2V3 -01#13(3$ V3#(3$ #VV(-$ 32#.(-$
5、2V- -01#13(2$ V3-#)(0$ V#VV()$ 3-#.(0$ 2V3 1#0(3$ V3V#(1$ )2#1(0$ V2#-(.$!0(30.0(3)0(.00(V0()-V0(1V)0()3.0(00(V-V0()-30(0010(0020(0-0表!两组乳腺癌患者的临床病理特征比较“#$%766544674?0$12 2+3#% *!79B-9!79BL:?6547685876:4?6?;576?5449B WK?6T969;?64?6:57:695T?67:64:7T76:;T7678:6?T?647;:67;T?6597?6:?6?9;4:65?:6:79:6:?:6:
6、?9:6554:6:;表8乳腺癌患者临床病理特征的单因素分析和多因素分析“#$%-/- +17%/3/7+,#04+%+)/7 .#*/#$%岁#国内乳腺癌患者的中位年龄比欧美国家提前了?:年左右$8%IAA6IBJ 1!67 5A?P6OQ QIRBSTIK6B%23* Q65OF4!67 5A?#%5BW6O#757JF7JWF 5BW6O BF7J7R76!,99,).8H.*?+IAAJ !FIA5 Z? %XX6W7 IX 5S6 IB 7U6 FROEJE5A IX NO65F7 W5BW6OV57J6B7F#Z$? %RO Z ;5BW6O!.=C!33%36B7O5A ;5BW
7、6O 6B7O5A ;5BW6O 6B7O5A;5BW6O !;OIKK6AJB 10!67 5A? ;U5BS6F JB AIBS76OK VOISBIFJF XIO NO65F7 W5BW6O JB 5 !R7WU W5BW6O O6SJF7OQ#Z$? 1Z!.=8!39=%3_61 ?!3 52 B52 6CB3A16636E3F1F:2516GH5D36 I1:6X D1436“%#N % Y4 0122 W:;X!#!ZQ$)% LY!O3361456X 6 I1:6X D1436$ $) I35;CC3;36“%#N =; %056A3;!ZQQ“!,+$ZZ%326X 0!01
8、2233 O!?1:;a:3 Y!3 52N056 F536G!;35436G 56E F5b121XIG;3253E Ab5;5A3;A6 b3 bXb21A52 ;3A:;36A3 ;53 C1221D6X H;356X b3;5FI 6I1:6X F5365A52 56E F;1X61A A1616c16 Y%!K3:H3;X M!e5I316F 1C F5365X3 1 F5b121XA C35:;336b 6 J6A12!ZQQ+!Z*$)%I I1:6X d1;356 H;35365X616 J6A12!#_P!#“$#_% 7%!e3;4566X b3;5FI C1; 6B56A
9、E36A3 6 I1:6X F536516 DbF11; B52“%#N V6 % L5E5 J6A12 =12 8bI YW!=33Ab3IGK3D456 K!MhY;X1 0!3 52N=;356145 6 D1436 5X3 #) I35;b 35;2IG6B5163GS3;b 13B3 H;35b VN=;356 5E123;b H;3521;3E;35436c16 %7!3 52NYET:B56 36E1A;63b3;5FI C1; F3;4361F5:b 35;2I H;356 5;2I =;353D X;1:FNj66Xb1;41635X166 F;34361F5:36b b1;
10、4163G;3A3F1;GF1B3 H;356EBE:52 F536 E55C;14 ;56E145261 S!2256 0!=3E6 Y!3 52N f1:6X 5X3 61:A C5A1; 6 H;3536!ZQP,!,$% $) I35;A %e!S32H3; LM!3 52N 7336X bXb2Xb1652 01645;I=;35;A %e!S32H3; LM!3 52N 7336X bXb2Xb1652 01645;I=;351652 016C3;36A3 16 YET:B56Ub3;5FI 1C 8;45;I =;356 J6A12!#_Z!ZQ$ZP% F536b 61E3G6
11、3X5B3 H;356C2:36A6Xb3 3CC3A 1C 5X3 16 F;1X616Xb3;5FI 1; 45g3E ;526J6A12!#_Z!ZQ$“%X6 C1; 6B56145 6 H;35B3;35436 6 ;32516 1 21A52 ;3A:;36A3 43E 1 I1:6XD1436 162I“%#N V6 % L5E5 J6A12 =12 8bIF3;221 U!W5C5 e!3 52N O16XG3;4 C1221DG:F 1C 5 F;1B3 F12AI 1C 45;X6GE;3A3E ;5E516 E116 6 H;356X b3;5FI“%#N 056A3;!
12、#_$!Q,$Z%3A:;36A3 ;6X b3;5FI 6 61E3G63X5B3F;34361F5:361F3;5B3 Ab341b3;5FI1F356 J;X56g516C1; L3B3S;1:F W:EI“%#N % 026 J6A12!#_!ZP$)%163 K!75;56 O!3 52N UD36IGI35; C1221DG:F 1C 5 ;56E14g3E 6X H;356X b ;5EA52 453A14I C1; 35;2I H;35 A56A3;“%#NK 6X2 %73E!#_#!$+,$Z“%&Z#,RZ#$#N!编辑“甘可建# 校对“夏宁静$“P#“Q#“Z_#“ZZ#“Z#“Z$#“Z+#“Z)#“Z“#“Z,#“ZP#“ZQ#“#_#“#Z#“#“#$#“#+#“#)#“#“#“#,#“#P#“#Q#“$_#“$Z#“$#“$#“$+#“$)#杨桦!等N华南地区年轻乳腺癌患者的临床特征及预后因素分析!“!#C MY K
